PerkinElmer gets regulatory nod in U.S. for coronavirus test

2020 03 25 23 03 8557 Perkinelmer Coronavirus Boxes 20200325230253

PerkinElmer is among the latest vendors to receive an emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for a reverse transcription polymerase chain reaction (RT-PCR) test for the novel coronavirus.

The agency's decision means CLIA-certified laboratories can immediately begin using the company's test kit to detect SARS-CoV-2, the virus that causes COVID-19, PerkinElmer said in a statement. The company also noted that the RT-PCR test meets the requirements of the European In Vitro Diagnostic Directive (IVDD) and is available in more than 30 countries worldwide.

Page 1 of 23
Next Page